Publications by authors named "Rahil Dahlen"

Claim this Profile
C
Corrigendum to "Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer's disease" [Clin. Mass Spectrom. 14 (Part B) (2019) 74-82].
Karl Hansson, Rahil Dahlén, Oskar Hansson, Elin Pernevik, Ross Paterson

J Mass Spectrom Adv Clin Lab· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide DNA Methylation Differences in Nonfunctioning Pituitary Adenomas With and Without Postsurgical Progression.
Tobias Hallén, Gudmundur Johannsson, Rahil Dahlén, Camilla A M Glad, Charlotte Örndal

J Clin Endocrinol Metab· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluid-based proteomics targeted on pathophysiological processes and pathologies in neurodegenerative diseases.
Ann Brinkmalm, Erik Portelius, Gunnar Brinkmalm, Josef Pannee, Rahil Dahlén

J Neurochem· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer's disease.
Karl Hansson, Rahil Dahlén, Oskar Hansson, Elin Pernevik, Ross Paterson

Clin Mass Spectrom· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer's disease: an update.
Erik Portelius, Gunnar Brinkmalm, Josef Pannee, Henrik Zetterberg, Kaj Blennow

Expert Rev Proteomics· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's disease.
Tobias Skillbäck, Niklas Mattsson, Karl Hansson, Ekaterina Mirgorodskaya, Rahil Dahlén

Sci Rep· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global mucosal and serum cytokine profile in patients with ulcerative colitis undergoing anti-TNF therapy.
Rahil Dahlén, Maria K Magnusson, Antal Bajor, Anders Lasson, Kjell-Arne Ung

Scand J Gastroenterol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis.
Maria K Magnusson, Rahil Dahlén, Hans Strid, Stefan Isaksson, Magnus Simrén

United European Gastroenterol J· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum IL-17A in newly diagnosed treatment-naive patients with ulcerative colitis reflects clinical disease severity and predicts the course of disease.
Lena Ohman, Rahil Dahlén, Stefan Isaksson, Asa Sjöling, Mary-Jo Wick

Inflamm Bowel Dis· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis